Immunic (IMUX) Preferred Dividend Payments (2013 - 2014)
Immunic's (IMUX) quarterly Preferred Dividend Payments came in at $4.7 million in Q2 2014, up 323.5% year-on-year from $1.1 million in Q2 2013, and up 54.92% quarter-over-quarter from $3.0 million in Q1 2014.
Immunic (IMUX) Preferred Dividend Payments (2013 - 2014) Analysis & Trends
Immunic has disclosed Preferred Dividend Payments across 2 years of filings, most recently posting $4.7 million for Q2 2014.
- Preferred Dividend Payments for Q2 2014 came in at $4.7 million, up 323.5% year-over-year; the trailing twelve-month figure through Sep 2015 was $4.7 million (down 66.4% YoY), and the FY2014 annual result was $4.4 million, down 30.03% from the prior year.
- Preferred Dividend Payments came in at $4.7 million for Q2 2014 at Immunic, up from $3.0 million in the prior quarter.
- In the past five years, Preferred Dividend Payments ranged from a high of $6.3 million in Q4 2013 to a low of $10000.0 in Q3 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | Immunic | 384.84 Mn | 198.21 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2014 | 4.72 Mn |
| Mar 31, 2014 | 3.05 Mn |
| Dec 31, 2013 | 6.28 Mn |
| Sep 30, 2013 | 10,000.00 |
| Jun 30, 2013 | 1.12 Mn |
| Mar 31, 2013 | 970,000.00 |